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The gene sequence of the Phaseolus vulgaris L. seed lectin-like protein (LLP) and its precursor (- 40 kDa) which is asso- 
ciated with the endoplasmic reticulum has been described, while the molecular characteristics of the mature protein and 
its cellular localization are still unknown. Our data, obtained using antibodies raised against a fusion protein, which was 
produced in Escherichia cofi and contained most of the LLP sequence, indicate that mature LLP accumulates in the pro- 
tein bodies of cotyledon cells. LLP consists of several polypeptides in the M, range 15 080 to 20 000, which are a result 
of proteolytic fragmentation of the protein precursor. 
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1. INTRODUCTION 
Two lectins accumulate at high levels in the seeds 
of the common bean (Phase&us vulgaris L.). 
These are phytohemagglutinin (PHA) and the 
related arcelin [1,2]. A cDNA, and the corre- 
sponding gene, coding for a lectin-like protein 
(LLP) have also been characterized [3,4]. It has 
been proposed that the genes coding for these pro- 
teins arose by divergence and duplication of a com- 
mon ancestral gene [5]. This evolution could be 
related to some advantage against insect predators, 
both arcelin and PHA being related to pest 
resistance [5,6]. This suggests that LLP might also 
play a similar defense role in the seed. To prove 
this hypothesis, it is necessary to identify LLP in 
bean seed extract and to purify it. 
In vitro translation of mRNA hybrid-selected 
using an LLP cDNA clone yielded a polypeptide of 
M, -28000 [7]. The cDNA sequence codes for a 
244 amino acid polypeptide comprising a 2 1 amino 
acid putative signal peptide and five potential N- 
glycosylation sites [3]. We have recently shown 
that, in the Greensleeves cultivar, newly- 
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synthesized LLP is an abundant glycopolypeptide 
of M, -40000, with probably four N-linked 
oligosaccharide side chains, and that it is 
associated with the endoplasmic reticulum (ER) of 
developing cotyledon cells [8]. None of the abun- 
dant polypeptides that were related to the LLP 
precursor have been identified so far in the seed, 
indicating that the protein either does not ac- 
cumulate or is processed to a mature form with 
markedly different electrophoretic mobility, as 
happens to other seed proteins [9]. 
To discriminate between these two possibilities 
we have raised antibodies against a fusion protein 
produced in E. coli, that contains most of the LLP 
amino acid sequence, and we have used these an- 
tibodies to challenge bean seed extracts. 
2. MATERIALS AND METHODS 
An 800 bp C/a1 fragment from plasmid pB7LLP [lo], con- 
taining the sequence coding for LLP amino acids 9-223, was 
end-filled and subcloned into the end-filled BamHI site of the 
expression vector pET3a [ll]. The ligation mixture was used to 
transform BL21(DE3) cells [12] and ampicillin-resistant col- 
onies were used to grow small overnight cultures. An ahquot of 
each culture was used to further inoculate 10 ml of liquid 
medium and expression was induced as described [121. Bacteria 
were collected by centrifugation, lysed in SDS-PAGE sample 
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buffer, and proteins were analyzed by SDS-PAGE [13]. Several 
clones expressing high levels of a 28 kDa protein were identified 
and one (pETLLPa1) was employed for antigen purification. 
Bacteria from 250 ml of induced culture were collected by cen- 
trifugation, resuspended in lysis buffer (50 mM Tris-Cl, pH 
7.4, 1 mg/ml lysozyme) and incubated for 30 min at 4°C. The 
suspension was then frozen and thawed 3 times before being 
centrifuged for 1 h at 41000 rpm in a Beckman TI 70.1 rotor, 
at 4°C. The pellet, containing most of the fusion protein, was 
resuspended in sample buffer and an aliquot was subjected to 
SDS-PAGE. The gel was stained with aqueous Coomassie 
(1 vol. of 3% Coomassie brilliant blue in methanol:4 vols of 
0.1 M Tris-Cl, pH 7.4) and the 28 kDa major band was excised. 
The gel slice was ground in a mortar and then incubated over- 
night at 4°C in elution buffer (50 mM Tris-Cl, pH 7.9, 0.1 mM 
EDTA, 1 mM DTT, 0.1 M NaCl, 0.1% SDS). The protein was 
recovered by precipitation with acetone and resuspended in elu- 
tion buffer. Production of immune sera against he fusion pro- 
tein (anti-LLP) and against PHA, purified from bean seed 
extract [14], was as described in [13]. 
Purification of polysomal RNA from developing bean (cv 
Greensleeves) cotyledons, construction of the plasmid pB7LLP 
and pB7lec1, in vitro transcription and translation were per- 
formed as in [lo]. When indicated, the in vitro translation 
system was supplemented with canine pancreatic microsomal 
membranes, according to manufacturer’s pecifications (Amer- 
sham, Bucks, England). ER-enriched subcellular fraction and 
protein bodies (PB) were isolated from developing cotyledons 
as described 1151. Total protein was extracted from mature 
seeds by homogenization in 20 mM Na borate, pH 9 (10 ml/g 
tissue), and proteins were recovered in the supernatant after 
20 min centrifugation at 20000 x g. SDS-PAGE and 
fluorography were as in [13]. Immunoprecipitation was accor- 
ding to [16], using the anti-LLP serum at a final dilution of 
1 :200. After SDS-PAGE, proteins were blotted on 
nitrocellulose sheets (S&S BA 85, 0.45 pm) and Western blot 
developed according to [17], using sera at a I : 500 dilution and 
peroxidase-linked anti-rabbit IgG (Miles) as the second an- 
tibody. When appropriate, 0.8 ml anti-LLP serum (diluted 
1: 16) were incubated overnight with about 400 Fg of PHA 
(purified on a thyroglobulin-Sepharose affinity resin) [14], 
either untreated or made 0.5% in SDS and denatured 5 min at 
90°C. 
3. RESULTS AND DISCUSSION 
Antibodies were raised in rabbit against an E. 
coli-synthesized fusion protein which contained 
most of the LLP sequence. To investigate whether 
these antibodies were able to crossreact against 
LLP, the plasmid pB7LLP, which contains the 
complete LLP sequence placed downstream of a 
T7 promoter, was used for in vitro transcription 
and the synthetic mRNA was translated in the 
reticulocyte system supplemented with labeled 
leucine. The products were then challenged with 
the immune serum. As controls for antibody 
specificity we used products of in vitro translation 
of both RNA and synthetic mRNA (obtained by in 
vitro transcription of plasmid pBi’lecl), of bean 
cotyledons, coding for the LLP-related E-PHA 
polypeptide. In fig.1, products selected by the im- 
mune serum (lanes 8-12) are compared with the 
same amount of starting material from which each 
selection was performed (lanes 2-6). Among the 
total products of bean RNA (lane 6), LLP 
(asterisk) and PHA subunits (E and L) have 
already been identified [7,8]. Synthetic LLP 
mRNA directed the synthesis of a major polypep- 
tide having the expected A4, (lane 4, Mr 28500) 
which was recognized by the antibodies (lane 10). 
When microsomal membranes were added to the in 
vitro translation system, to allow for signal peptide 
removal and glycosylation [18], in addition to 
unglycosylated LLP, three slower migrating LLP 
glycopolypeptides were immunoselected (lane 11, 
dots). Both glycosylated and unglycosylated forms 
of LLP were almost quantitatively selected by the 
antibodies (cf. lanes 10 and 11 with lanes 4 and 5). 
The two fastest migrating immunoselected 
polypeptides in lanes 10 and 11 have not been in- 
vestigated further but probably represent 
precociously terminated LLP. The related 
polypeptide E-PHA was weakly recognized when 
unglycosylated (cf. lanes 2 and 8), while its abun- 
dant glycosylated form, synthesized when mem- 
branes were added to the translation system, was 
barely detectable among the immunoselected 
material (arrowheads in lanes 3 and 9). The mobili- 
ty of glycosylated E-PHA indicates that it has two 
oligosaccharide side chains, as bean-synthesized 
PHA. Immunoselection of in vitro translation pro- 
ducts of cotyledon mRNA confirmed that LLP 
was almost quantitatively selected (cf. lanes 6 and 
12), and showed that L-PHA crossreacted with the 
antibodies more efficiently than E-PHA, although 
at levels much lower than LLP. The result shown 
in lane 12 also indicates that there was no 
crossreaction between the immune serum and the 
two polypeptides of the major storage protein 
phaseolin (open circles in lane 6). 
Having determined that our anti-serum 
crossreacted with in vitro synthesized LLP, we 
looked for the presence of immunologically related 
polypeptides in bean seeds. Total protein contain- 
ed in the protein bodies (PB) and ER-enriched 
preparations from developing cotyledons, and in a 
total protein extract from mature seeds, was 
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Fig.1. SDS-PAGE and fluorography of in vitro synthesized 
LLP and PHA. Reticulocyte lysate was supplemented with 
[3H]leucine and: E-PHA in vitro transcript (E-PHA), LLP in 
vitro transcript (LLP), bean cotyledon RNA (Tot), no RNA 
(-). DPM: with (+) or without (-) microsomal membranes 
added. Lanes 2-7, total products. Lanes 8-12, material 
immunoselected with the anti-LLP serum. Lanes 1 and 13, 
molecular mass markers. Lanes 6, 12 and 13 were from a 
shorter exposure of the SDS-PAGE. 
separated by SDS-PAGE and subjected to Western 
blot analysis. An anti-PHA serum, used as a con- 
trol, recognized PHA purified on a thyroglobulin- 
Sepharose affinity column (fig.2, lane 1) [14], as 
well as PHA contained in the PB extract or ac- 
cumulated in the mature seed (lanes 3 and 2, 
respectively). PHA precursor associated with the 
ER, which has a lower electrophoretic mobility 
compared to mature PHA [14], could also be 
detected (lane 4). 
The anti-LLP serum recognized five polypep- 
tides from the ER preparation (lane 6). Among 
these components, two can be purified on a 
thyroglobulin affinity column and represent ER- 
associated PHA (lane 5). The other three polypep- 
tides, which have dectrophoretic mobilities iden- 
tical with glycosylated LLP polypeptides 
synthesized in vitro (fig.1, lane 11 dots), must 
represent he newly synthesized glycosylated LLP 
precursor. The presence of three polypeptides in 
vivo, as well as in vitro, indicates that LLP can 
have different levels of glycosylation, as is the case 
with phaseolin polypeptides 1131. The slowest 
migrating glycosylated polypeptide, which cor- 
responds to the 40 kDa LLP glycopolypeptide we 
have previously identified, has, most probably, 
four oligosaccharide side chains [8]. The relative 
mobility of the other two glycosylated pohw- 
Seed 
extracts: 
567 8 9 10 11 12 
kDa 
Fig.2. Western blot analysis of seed proteins. Proteins contained in: total protein extract from mature seeds (TOT) and either protein 
bodies (PB) or ER-enriched (ER) preparations from developing cotyledons were loaded on the SDS-PAGE. Affinity purified PHA 
was from mature seeds (PB-PHA) and from ER-enriched preparation of developing cotyledons (ER-PHA). Bean cultivars were: Pinto 
UI 111 (lane 10) and Greensleeves (other lanes). Immune sera were: anti-PHA (lanes l-4), anti-LLP (lanes 5-lo), anti-LLP after 
incubation with denatured PHA (lanes 11 and 12). Position of molecular mass markers is given on the right. 
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tides, also with respect to PHA, suggests the 
presence of three and two side chains. Having 
entered the secretory pathway of the cell, the LLP 
precursor could then be transported to the storage 
compartment, the PB, where the homologous pro- 
teins PHA and arcelin accumulate. Among the 
proteins present in a PB preparation, anti-LLP 
serum selected, in addition to mature PHA, at 
least five polypeptides, with molecular masses in 
the range of 15 to 20 kDa (fig.2, lane 7, vertical 
bar). This indicates that LLP leaves the ER and is 
transported into the PB and that, during transport 
or after arrival to the PB, LLP undergoes further 
post-translational processing, as is the case for 
other lectins and storage proteins [9]. The ratio 
between LLP and PHA in the PB of developing 
cotyledons (lane 7) is similar to that found in the 
mature seed (cf. with lane 8). LLP therefore is a 
protein that accumulates during seed development. 
The results shown above were confirmed by 
analysis of a total protein extract from mature 
seeds of the Pinto UI 111 cultivar, a cultivar lack- 
ing PHA [19]. Developing cotyledons of this 
cultivar contain LLP mRNA and the ER- 
associated protein precursor at a level comparable 
to the one determined in the Greensleeves cultivar 
[7,8]. Analysis of the Pinto UI 111 seed extract 
showed that LLP accumulates also in this cultivar 
(lane lo), and evidenced the presence of elec- 
trophoretic polymorphism between mature LLP of 
the two cultivars, a common feature of seed pro- 
teins [9]. As expected, no crossreactive material 
was present in the PHA region of the gel (lane 10). 
Finally, it is of interest to note that the anti-LLP 
serum used strongly recognized glycosylated PHA 
when denatured and blotted (fig.2), while it 
reacted to a lesser extent with glycosylated PHA in 
native conditions (fig. 1, arrowheads in lanes 3 and 
9). The hypothesis that the difference in reaction 
could be due to denaturation was verified by the 
following experiment.‘The anti-LLP serum was in- 
cubated with an excess of PHA, either native or 
denatured for 5 min at 9O”C, and then used for 
Western blot analysis. Pre-incubation with native 
PHA did not affect reaction on the blot (the result 
was identical to lanes 6 and 8 in fig.2), while 
denatured PHA blocked to a great extent detection 
of PHA on the blot, affecting only slightly detec- 
tion of LLP (lanes 11 and 12). This would suggest 
that the observed crossreactivity is mainly due to 
160 
the presence of one or more common 
denaturation-dependent epitopes on PHA and 
LLP, while epitopes exposed on the surface of the 
native proteins are less conserved. Furthermore, 
this partial crossreactivity strengthens the idea of a 
common origin for LLP, PHA and arcelin. The 
determination of the molecular characteristics of 
mature LLP and its presence as a stable protein in 
the seed opens the way to its purification and in- 
vestigation of its function. 
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